Harvard Apparatus Regenerative Technology Inc.
Income Statement
| Line Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $82.0K | $118.0K | $93.0K | $22.0K | $0 |
| Cost of Revenue | $116.0K | $139.0K | $48.0K | $11.0K | $0 |
| Gross Profit | $-34.0K | $-21.0K | $45.0K | $11.0K | $0 |
| Gross Margin | -41.5% | -17.8% | 48.4% | 50.0% | — |
| Operating Expenses | |||||
| Research & Development | $7.6M | $4.8M | $5.1M | $4.6M | $4.0M |
| SG&A Expense | $4.5M | $6.9M | $5.7M | $4.0M | $2.6M |
| Operating Income | $-12.1M | $-11.7M | $-11.1M | $-8.8M | $-6.7M |
| Operating Margin | -14,787.8% | -9,916.1% | -11,889.2% | -40,077.3% | — |
| Interest Expense | — | — | — | — | — |
| Pretax Income | $-11.6M | $-11.7M | $-11.1M | $-8.8M | $-6.7M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-11.6M | $-11.7M | $-11.1M | $-8.8M | $-6.7M |
| Net Margin | -14,120.7% | -9,918.6% | -11,893.5% | -40,077.3% | — |
| EPS (Basic) | $-14.49 | $-1.05 | $-1.41 | $-1.14 | $-0.87 |
| EPS (Diluted) | $-14.49 | $-1.05 | $-1.41 | $-1.14 | $-0.87 |
| Shares Outstanding (Basic) | 855.4K | 14.1M | 7.9M | 7.7M | 0 |
| Shares Outstanding (Diluted) | 855.4K | 14.1M | 7.9M | 7.7M | 0 |
| Dividends Per Share | — | — | — | — | — |